The Guide-it CRISPR/Cas9 Gesicle Production System is a system for producing high yields of target-specific CRISPR/Cas9 gesicles for gene editing. Gesicles are cell-derived nanovesicles used to deliver macromolecular cargoes to a broad range of target cells, including cells that are difficult to transfect with plasmids. The nanovesicles are produced in a Gesicle Producer 293T Cell Line (Cat. No. 632617) via co-overexpression of packaging mix components, which include a nanovesicle-inducing glycoprotein and a protein that is displayed on the cell surface that mediates binding and fusion with the cellular membrane of target cells. Simultaneous overexpression of additional macromolecular cargoes, in this case the Cas9 protein from Streptococcus pyogenes and a target-specific guide RNA (sgRNA), results in incorporation of the Cas9/sgRNA complex within the gesicles. After the resulting Cas9/sgRNA gesicles are harvested and applied to your target cells in the presence of protamine sulfate, they will efficiently enter the cells and mediate gene editing. This system provides the components needed to clone and express your target-specific guide RNA, and packaging reagents to produce CRISPR/Cas9 gesicles. It is essential to use the pGuide-it-sgRNA1 Vector for expression and packaging of your guide RNA, since using other commonly used guide RNA vectors will not result in effective Cas9/sgRNA complexes.
Overview
- Broad tropism: Efficient delivery of active Cas9 protein and target-specific sgRNA to a broad range of cell types
- Reduced off-target effects: Delivery of Cas9 protein eliminates genomic integration and reduces off-target effects
- Genome editing only when you want it: Tight control over dose and timing of delivery and editing
- Notes:
- The traditional guide RNA scaffold provided with most commonly used vectors will not work with Cas9 delivered using gesicle technology. It is essential to use the pGuide-it-sgRNA1 Vector supplied in Cat. # 631613 or Cat. # 631612 when making gesicles, since this vector contains an optimized scaffold sequence for increased assembly and stability.
- The Gesicle Producer 293T Cell Line is not provided with the system and may be purchased separately (Cat. # 632617)
- Stem cell applications: We have demonstrated high-efficiency editing of endogenous genes in human iPS cells using a combination of CRISPR/Cas9 gesicles and our DEF-CS culture system.
- Note regarding primary CD34+ cells and primary T cells: While CRISPR/Cas9 gesicles have worked well in editing hard-to-transfect cell lines such as Jurkat cells, we have so far been unable to demonstrate high editing efficiency in primary CD34+ cells and primary T cells.
Applications
- CRISPR/Cas9-mediated gene editing
- Stem cell research






